The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...
Alphabet spinoff SandboxAQ — an AI and quantum computing startup — added another $150 million to its Series E from the likes ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results